Cite
HARVARD Citation
Casey, M. et al. (2022). Are Pivotal Clinical Trials for Drugs Approved for Leukemias and Multiple Myeloma Representative of the Population at Risk?. Journal of clinical oncology. 40 (32), pp. 3719-3729. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Casey, M. et al. (2022). Are Pivotal Clinical Trials for Drugs Approved for Leukemias and Multiple Myeloma Representative of the Population at Risk?. Journal of clinical oncology. 40 (32), pp. 3719-3729. [Online].